JESSICA MITCHELL: Open Payments
NPI 1962020115 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$543 in 29 payments from 9 companies in 2025. Trend: 2023 $684 · 2024 $511 · 2025 $543
Food & beverage: $543
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $151 |
| Vanda Pharmaceuticals Inc. | 4 | $97 |
| Gilead Sciences, Inc. | 3 | $85 |
| ABBVIE INC. | 3 | $57 |
| Novo Nordisk Inc | 2 | $46 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| Supernus Pharmaceuticals, Inc. | 1 | $28 |
| Alkermes, Inc. | 1 | $27 |
| Lilly USA, LLC | 1 | $16 |
Products named: CAPLYTA, HETLIOZ, REXULTI, Qelbree, LYBALVI, MAVYRET, QULIPTA, VRAYLAR.
Industry payments across TN — which companies pay providers there.
